1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Latvia Pharmaceuticals and Healthcare Report Q2 2016

Latvia Pharmaceuticals and Healthcare Report Q2 2016

  • March 2016
  • -
  • Business Monitor International
  • -
  • 79 pages

Includes 3 FREE quarterly updates

BMI View: The outlook for Latvia's pharmaceutical and healthcare markets will be primarily driven by thegovernment's fiscal austerity measures. The healthcare sector, already severely underfunded, will strugglegiven cuts and place more emphasis on the private sector. Growth in the pharmaceutical sector will belimited by an increasing preference for generic substitution despite a transparent regulatory environment.

Headline Expenditure Projections

- Pharmaceuticals: EUR338mn (USD372mn) in 2015 to EUR353mn (USD377mn) in 2016; +4.4% inlocal currency terms and 1.5% in US dollar terms. Forecast unchanged from previous quarter.

- Healthcare: EUR1.01n (USD1.11bn) in 2015 to EUR1.05bn (USD1.13bn) in 2015; +4.2% in localcurrency terms and 1.4% in US dollar terms. Forecast unchanged on previous quarter.

Table Of Contents

Latvia Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Latvia 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Latvia 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Latvia 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Latvia 2012-2020) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Latvia 2012-2020) 15
Prescription Drug Market Forecast 16
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Latvia 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Latvia 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Latvia 2012-2020) 22
OTC Medicine Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Latvia 2012-2020) 24
Pharmaceutical Trade Forecast 25
Table: Pharmaceutical Trade Data And Forecasts (Latvia 2014-2020) 26
Table: Pharmaceutical Trade Data And Forecasts local currency (Latvia 2014-2020) 27
Pharmaceuticals and Healthcare Risk/Reward Index 28
Central And Eastern Europe Risk/Reward Index 28
Latvia Risk/Reward Index 34
Rewards 34
Risks 34
Regulatory Review 36
Regional Collaboration 37
Intellectual Property 38
Pricing Regime 38
Reimbursement Regime 40
Market Overview 42
Healthcare Sector 43
Table: Healthcare Resources (Latvia 2010-2015) 45
Table: Hospitals and Beds, 2006-2010 45
Table: Hospital Beds by Specialty, 2004-2010 46
Table: Healthcare Personnel (Latvia 2010-2015) 47
Table: Healthcare Activity (Latvia 2010-2015) 47
Research and Development 48
Biotechnology 48
Clinical Trials 50
Epidemiology 51
Table: Cumulative Reported Cases of HIV and AIDS, 2000-2010 53
Competitive Landscape 54
Research-Based Industry 54
Table: Multinational Market Activity 55
Generic Drugmakers 56
Pharmaceutical Distribution 56
Pharmaceutical Retail Sector 58
Company Profile 60
Grindeks 60
Olainfarm 64
Demographic Forecast 68
Table: Population Headline Indicators (Latvia 1990-2025) 69
Table: Key Population Ratios (Latvia 1990-2025) 69
Table: Urban/Rural Population and Life Expectancy (Latvia 1990-2025) 70
Table: Population By Age Group (Latvia 1990-2025) 70
Table: Population By Age Group % (Latvia 1990-2025) 71
Glossary 73
Methodology 75
Pharmaceutical Expenditure Forecast Model 75
Healthcare Expenditure Forecast Model 75
Notes On Methodology 76
Risk/Reward Index Methodology 77
Index Overview 78
Table: Pharmaceutical Risk/Reward Index Indicators 78
Indicator Weightings 79

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.